P53 and breast cancer, an update

被引:300
作者
Lacroix, Marc [1 ]
Toillon, Robert-Alain [1 ]
Leclercq, Guy [1 ]
机构
[1] Free Univ Brussels, Inst Jules Bordet, Lab Jean Claude Heuson Cancerol Mammaire, B-1000 Brussels, Belgium
关键词
D O I
10.1677/erc.1.01172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53 plays a key role in mediating cell response to various stresses, mainly by inducing or repressing a number of genes involved in cell cycle arrest, senescence, apoptosis, DNA repair, and angiogenesis. According to this important function, p53 activity is controlled in a very complex manner, including several auto-regulatory loops, through the intervention of dozens of modulator proteins (the 'p53 interactome'). p53 mutations are observed in a significant minority of breast tumours. In the remaining cases, alterations of interactome components or target genes could contribute, to some extent, to reduce the ability of p53 to efficiently manage stress events. While the prognostic and predictive value of p53 is still debated, there is an increasing interest for p53-based therapies. The present paper aims to provide updated information on p53 regulation and function, with specific interest on its role in breast cancer.
引用
收藏
页码:293 / 325
页数:33
相关论文
共 209 条
[1]   Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].
Aas, T ;
Borresen, AL ;
Geisler, S ;
SmithSorensen, B ;
Johnsen, H ;
Varhaug, JE ;
Akslen, LA ;
Lonning, PE .
NATURE MEDICINE, 1996, 2 (07) :811-814
[2]   Prognostic relevance of gene amplifications and coamplifications in breast cancer [J].
Al-Kuraya, K ;
Schraml, P ;
Torhorst, J ;
Tapia, C ;
Zaharieva, B ;
Novotny, H ;
Spichtin, H ;
Maurer, R ;
Mirlacher, M ;
Köchli, O ;
Zuber, M ;
Dieterich, H ;
Mross, F ;
Wilber, K ;
Simon, R ;
Sauter, G .
CANCER RESEARCH, 2004, 64 (23) :8534-8540
[3]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[4]   p53 proteasomal degradation - Poly-ubiquitination is not the whole story [J].
Asher, G ;
Shaul, Y .
CELL CYCLE, 2005, 4 (08) :1015-1018
[5]   The role of p53 in tumour suppression: lessons from mouse models [J].
Attardi, LD ;
Jacks, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :48-63
[6]   The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription [J].
Banerjee, S ;
Kundu, TK .
NUCLEIC ACIDS RESEARCH, 2003, 31 (12) :3236-3247
[7]   Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7 [J].
Bao-Lei, T ;
Zhu-Zhong, M ;
Yi, S ;
Jun-Jie, Q ;
Yan, D ;
Hua, L ;
Bin, L ;
Guo-Wei, Z ;
Zhi-Xian, S .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (03) :561-571
[8]  
Barbareschi M, 1996, APPL IMMUNOHISTOCHEM, V4, P106
[9]   A global suppressor motif for p53 cancer mutants [J].
Baroni, TE ;
Wang, T ;
Qian, H ;
Dearth, LR ;
Truong, LN ;
Zeng, J ;
Denes, AE ;
Chen, SW ;
Brachmann, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :4930-4935
[10]   ASPP1 and ASPP2: Common activators of p53 family members [J].
Bergamaschi, D ;
Samuels, Y ;
Jin, BQ ;
Duraisingham, S ;
Crook, T ;
Lu, X .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :1341-1350